Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 18:33:38 GMT 2025
by
admin
on
Mon Mar 31 18:33:38 GMT 2025
|
| Protein Type | FC FUSION PROTEIN |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
SU09HUV8AJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78275
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
||
|
FDA ORPHAN DRUG |
215305
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
204658-47-9
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
PRIMARY | |||
|
DB06256
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
PRIMARY | |||
|
OO-08
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
PRIMARY | |||
|
8337
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108056
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
PRIMARY | |||
|
300000014082
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
PRIMARY | |||
|
C152697
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
PRIMARY | |||
|
SU09HUV8AJ
Created by
admin on Mon Mar 31 18:33:38 GMT 2025 , Edited by admin on Mon Mar 31 18:33:38 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_51 | 2_51 |
| 1_54 | 2_54 |
| 1_86 | 1_146 |
| 1_192 | 1_250 |
| 2_86 | 2_146 |
| 2_192 | 2_250 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_24 |
| N | 1_122 |
| N | 2_24 |
| N | 2_122 |
| O | 1_16 |
| O | 2_16 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_1] [2_1] | N-TERMINUS | PIDOLIC ACID | SZB83O1W42 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|